Navigation Links
Molecular DNA switch found to be the same for all life

The molecular machinery that starts the process by which a biological cell divides into two identical daughter cells apparently worked so well early on that evolution has conserved it across the eons in all forms of life on Earth. Researchers with the U.S. Department of Energy's Lawrence Berkeley National Laboratory and the University of California at Berkeley have shown that the core machinery for initiating DNA replication is the same for all three domains of life - Archaea, Bacteria and Eukarya.

In two papers that will be concurrently published in the August edition of the journal Nature Structural and Molecular Biology (now available on-line), the researchers report the identification of a helical substructure within a superfamily of proteins, called AAA+, as the molecular "initiator" of DNA replication in a bacteria, Escherichia coli (E. coli), and in a eukaryote, Drosophila melanogaster, the fruit fly. Taken with earlier research that identified AAA+ proteins at the heart of the DNA replication initiator in archaea organisms, these new findings indicate that DNA replication is an ancient event that evolved millions of years ago, prior to when Archaea, Bacteria and Eukarya split into separate domains of life.

"The ability of a cell to replicate its DNA in a timely and faithful manner is fundamental for survival, but, despite decades of study, the structural and molecular basis for initiating DNA replication, and the degree to which these mechanisms have been conserved by evolution have been ill defined and hotly debated," said biophysicist Eva Nogales, a collaborator on the Drosophila study.

Said biochemist Michael Botchan, also a collaborator on the Drosophila study, "Our two papers fuse together a number of biophysical research techniques to take our understanding of the mechanics of DNA opening and replisome construction to a new level."

Biochemist and structural biologist James Berger, a participant in both studies a
'"/>

Source:DOE/Lawrence Berkeley National Laboratory


Page: 1 2 3 4 5

Related biology news :

1. Molecular biology fills gaps in knowledge of bat evolution
2. Molecular machine may lead to new drugs to combat human diseases
3. Molecular Motors Cooperate In Moving Cellular Cargo, Study Shows
4. Molecular models advance the fight against malaria
5. Molecular fossils uncover link between viruses and the immune system
6. Molecular thermometers on skin cells detect heat and camphor
7. Molecular messengers perform a crucial role in the ability of injured nerve cells to heal themselves
8. Molecular steps involved in the creation of gene-silencing microRNAs identified
9. Molecular miners find pain relief drugs from the sea
10. Molecular mechanism of feather formation found
11. Molecular trigger for Huntingtons disease found
Post Your Comments:
(Date:12/5/2009)... research into venom produced by snakes and spiders, venomous ... mystery. Now, a study of 158 catfish species, published ... , has catalogued the presence of venom glands and ... from the University of Michigan, USA, carried out the ... to elucidate the diversity and distribution of venomous catfish. ...
(Date:12/4/2009)... to an analysis of statewide data taken from 1998-2001, ... year were more than three times likely to report ... their insurance status during pregnancy and delivery. , ... times more likely among mothers with Medicaid coverage, and ...
(Date:12/4/2009)... is widely used by physicians and scientists to study ... has remained largely unknown whether the electrodes on the ... inside the brain. Scientists at the Max Planck Institute ... a crucial link between the activity generated within the ...
Breaking Biology News(10 mins):Lower income women report more insurance-based discrimination during pregnancy, delivery 2How to read brain activity? 2Prostate Net Announces 3A Release of La Prostata Red The Prostate Net En Espanol 57016 1Prostate Net Announces 3A Release of La Prostata Red The Prostate Net En Espanol 57016 2NCCN Holds Oncology Research Best Practices Conference 57014 1NCCN Holds Oncology Research Best Practices Conference 57014 2NCCN Holds Oncology Research Best Practices Conference 57014 3David Duncan Has a Prescription for American Health Care 57012 1David Duncan Has a Prescription for American Health Care 57012 2David Duncan Has a Prescription for American Health Care 57012 3
... of Saxony-Anhalt most often suffers from obesity and ... Hans Hauner of Munich Technical University and his ... differences in prevalence in general medical care. Their ... Deutsches rzteblatt International ( Dtsch Arztebl ...
... turtle,s first swim is the most critical of its life. Having ... to the sea, the tiny voyager must also evade hungry fish ... on the Great Barrier Reef,s coral cays the risks are high: ... waters. But how much does this headlong dash through the waves ...
... elegant solution to a sticky scientific problem in basic ... an even rate, but instead forms what look like ... these rivulets "gravity fingers," and the explanation for their ... the wateror any liquidmeets the soil (or other medium). ...
Other Biology News:Cost of hatchling turtles' dash for freedom 2MIT researchers explain mystery of gravity fingers 2
(Date:12/2/2009)... Reportlinker.com announces that a new market ... ,, Drug Discovery Technologies - A ... ,, http://www.reportlinker.com/p0164246/Drug-Discovery-Technologies---A-Global-Update-of-Market-Trends--Opportunities.html ,, Drug ... element of every pharmaceutical company,s business strategy. ...
(Date:12/2/2009)... ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced ... offering, the underwriters have exercised in full their over-allotment ... is comprised of one common share and 0.4 of ... a price of US$3.00 per unit. Each whole common ...
(Date:12/2/2009)... Israel, December 2 Gamida Cell announced today,a ... and,efficacy of a gene therapy product which combines ... The product may have potential to,treat inherited anemias ... Gamida Cell is developing a series of ...
(Date:12/2/2009)... QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zentaris ... "Company"), a global biopharmaceutical company focused on endocrine ... Food and Drug Administration (FDA) has granted Fast ... compound, perifosine (KRX-0401), for the treatment of relapsed/refractory ...
Breaking Biology Technology:Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3
... June 16 Lentigen Corporation today announced,the ... vice president of corporate,development. In addition to ... Dr. Meade will be responsible for managing ... and intellectual,property portfolios, contract negotiations, and other ...
... BOCA RATON, Fla., June 16 NovaVision today ... chief executive officer. In,his role, Mazzocchi is responsible ... channels of growth to ensure that patients with,impaired ... Mazzocchi has 25 years of expertise bringing ...
... Blum Will Help Drive the Commercialization of Company,s Cancer ... ... Computational Technologies,(AppCompTech) has announced the appointment of Kathy Blum as the ... and IT related businesses as well as global experience with,start-ups and ...
Other Biology Technology:Lentigen Appoints Jim Meade as Vice President of Corporate Development 2NovaVision Appoints Medical Technology Veteran Rudy Mazzocchi as Chief Executive Officer 2NovaVision Appoints Medical Technology Veteran Rudy Mazzocchi as Chief Executive Officer 3Applied Computational Technologies Appoints a New CEO 2
Anti-Mouse C-10, Biotin (Polyclonal) (rabbit IgG)...
Goat polyclonal to SART3 ( Abpromise for all tested applications). Antigen: Synthetic peptide: MSNADFAKLFLRK, corresponding to C terminal amino acids 951-963 of Human SART3 Entrez Gene ID: 9...
... to detect the appearance of AcNPV gp64 ... as early as 8-24 hours post-infection. This ... Kit, which allows determination of baculovirus titers ... FastPlax Antibody can also be used to ...
Alexa Fluor 647 anti-mouse IL-12 (Interleukin-12) / IL-23 (Interleukin-23) p40 25 ug...
Biology Products: